Skip to main content

Arkadios Wealth Advisors

Position in MRK — Merck & Co., Inc.

CIK 1800798 ATLANTA, GA

Position in MRK

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$18,114,387
+$536,290 QoQ
Shares Held
140,968
-3.5% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
#553
of 3,778 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MRK Over Time

Shares Held

Position Value (USD)

Derivatives in MRK

reported options exposure · as of Jun 30, 2026
CallValue
$102,800
CallShares
800
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Arkadios Wealth Advisors holds $175,268,765 across 14 Drug Manufacturers - General names. MRK ranks #4 (10.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 MRK
Merck & Co., Inc.
This page
140,968 $18,114,387

All Filings in MRK

Export CSV
31 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $18,114,387 140,968
2026-06-30 $102,800 800
2026-03-31 $96,232 800
2026-03-31 $17,578,097 146,131
2025-12-31 $84,208 800
2025-12-31 $14,841,869 141,002
2025-09-30 $6,711,545 79,966
2025-09-30 $67,144 800
2025-06-30 $5,310,131 67,081
2025-06-30 $63,328 800
2025-03-31 $4,084,079 45,500
2024-12-31 $3,640,072 36,591
2024-09-30 $4,838,678 42,609
2024-06-30 $5,181,277 41,852
2024-03-31 $4,195,350 31,795
2023-12-31 $2,784,915 25,545
2023-09-30 $2,861,804 27,798
2023-06-30 $1,971,322 17,084
2023-03-31 $1,813,204 17,043
2022-12-31 $1,915,107 17,261
2022-09-30 $1,460,336 16,957
2022-06-30 $1,410,855 15,475
2022-03-31 $1,168,556 14,242
2021-12-31 $1,091,123 14,237
2021-09-30 $1,174,119 15,632
2021-06-30 $1,348,142 17,335
2021-03-31 $949,286 12,314
2020-12-31 $797,795 9,753
2020-09-30 $522,170 6,295
2020-06-30 $483,467 6,252
2020-03-31 $410,782 5,339